Learning More About The Placebo Effect Jul 6, 2009
ScienceDaily (July 6, 2009) In a recent trial, a sample of alcohol-dependent patients received naltrexone, acamprosate or placebo for 12 weeks ... Reanalysis of a clinical trial of naltrexone and acamprosate for alcohol dependence investigated this issue further ... In this trial, 169 alcohol-dependent patients received naltrexone, acamprosate or placebo for 12 weeks. (Science Daily)
Naltrexone Can Help Heavy Social Drinkers Quit Smoking Mar 26, 2009
24, 2007) A recent large multicenter research study of alcohol dependence suggested that naltrexone produced a modest but significant benefit but another FDA-approved medication, acamprosate, was ineffective. (May 17, 2005) Once-a-month, long acting injections of the drug naltrexone, combiined with psychotherapy, signficantly reduced heavy drinking in patients being treated for alcohol. (Science Daily)
Hormone Drug May Help Drinkers Stay Sober Mar 3, 2009
Only three medications have FDA approval for treating alcohol dependence -- disulfiram (Antabuse), naltrexone (Depade, ReVia), and acamprosate (Campral). The U.S. National Institutes of Health estimates that almost 18 million people in the United States -- approximately one in every 12 adults -- abuses alcohol or is alcohol-dependent. (MEDLINEplus)
Hormone Disorder Drug Could Help Drinkers Stay Sober Feb 26, 2009
But there are just three medications approved to treat alcohol dependence disulfiram (Antabuse), naltrexone (Depade, ReVia), and acamprosate (Campral). Lead author of the study is Sebastien Carnicella, PhD, postdoctoral fellow at the Gallo Center. (Science Daily)
